A Phase II, Placebo-Controlled, Double-Blind, Dose-Ranging (35mg/Day or 70 mg/Day), Randomized, Study of Cutaneous Dihydrotestosterone (DHT)-Gel (0.7% Hydroalcoholic Gel) in Older Hypogonadal Males Ages 55-80 Years: Effect on Body Composition, Libido, and Physical and Sexual Functioning

NCT00163566 Phase 2 COMPLETED

The purpose of this study is to evaluate whether DHT-Gel, when applied daily to the skin, can relieve the symptoms of low testosterone in men aged 55-80. These symptoms include reduced muscle strength, increase fat mass, low libido, feeling blue or moody

Details

Lead sponsor	ASCEND Therapeutics
Phase	Phase 2
Status	COMPLETED
Enrolment	128
Start date	2004-10
Completion	2006-09-25

Conditions

• Hypogonadism
• Late Onset Hypogonadism
• Low Testosterone

Interventions

• Dihydrotestosterone (0.7%) in hydroalcoholic gel

Primary outcomes

• Change in Body Composition

Countries

United States